CS logo
small CS logo
KM Management spol. s r.o.

Nitra, Slovakia
Doctor in Nitra
Špitálska 563, 949 01 Nitra

About KM Management spol. s r.o.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
10
Celgene
7
Shire
7
Hoffmann-La Roche
4
Galapagos NV
3
Takeda
3
Arena Pharmaceuticals
2
Eli Lilly and Company
2
Ferring Pharmaceuticals
1
Gilead Sciences
1
VHsquared Ltd.
1
Total Rows: 12

Clinical Trials at KM Management spol. s r.o.


During the past decade, KM Management spol. s r.o. conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 25 clinical trials were completed, i.e. on average, 75.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 16 clinical trials were completed. i.e. 533.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years775566884433111133113311Started TrialsCompleted Trails2015201620172018201920200246810
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study To Monitor Long-Term Treatment With PF-00547659
2011-07-01
2016-07-27
Completed
268
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
2012-07-20
2016-05-27
Completed
593
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
2012-06-01
2015-06-01
Completed
547
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
2012-10-01
2020-08-06
Completed
944
Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis
2012-04-01
2013-12-01
Terminated
147
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
2012-11-02
2016-02-04
Completed
357
Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation
2013-04-01
2014-04-01
Terminated
314
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822

Rows per page:

1–42 of 42

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "KM Management spol. s r.o." #1 sponsor was "Pfizer" with 10 trials, followed by "Celgene" with 7 trials sponsored, "Shire" with 7 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Galapagos NV" with 4 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "KM Management spol. s r.o." #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 10Pfizer: 10Celgene: 7Celgene: 7Shire: 7Shire: 7Hoffmann-La Roche: 4Hoffmann-La Roche: 4Galapagos NV: 3Galapagos NV: 3Takeda: 3Takeda: 3Arena Pharmaceuticals: 2Arena Pharmaceuticals: 2Eli Lilly and Company: 2Eli Lilly and Company: 2Ferring Pharmaceuticals: 1Ferring Pharmaceuticals: 1Gilead Sciences: 1Gilead Sciences: 1

Created with Highcharts 11.1.0Top CollaboratorsGilead Sciences: 3Gilead Sciences: 3Arena is a whollyowned subsidiary ofPfizer: 2Arena is a whollyowned subsidiary ofPfizer: 2Galapagos NV: 1Galapagos NV: 1

Clinical Trials Conditions at KM Management spol. s r.o.


According to Clinical.Site data, the most researched conditions in "KM Management spol. s r.o." are "Ulcerative Colitis" (19 trials), "Crohn's Disease" (10 trials), "Crohn Disease" (7 trials), "Colitis, Ulcerative" (4 trials) and "Chronic Idiopathic Constipation" (1 trials). Many other conditions were trialed in "KM Management spol. s r.o." in a lesser frequency.

Clinical Trials Intervention Types at KM Management spol. s r.o.


Most popular intervention types in "KM Management spol. s r.o." are "Drug" (40 trials), "Other" (8 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (23 trials), "Etrasimod" (4 trials), "Etrolizumab" (4 trials), "Filgotinib" (4 trials) and "GED-0301" (4 trials). Other intervention names were less common.

Clinical Trials Genders at KM Management spol. s r.o.


The vast majority of trials in "KM Management spol. s r.o." are 42 trials for "All" genders.

Clinical Trials Status at KM Management spol. s r.o.


Currently, there are NaN active trials in "KM Management spol. s r.o.". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in KM Management spol. s r.o., undefined suspended trials, and 8 terminated clinical trials to date.
Out of the total trials that were conducted in KM Management spol. s r.o., 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 33Phase 3: 33Phase 2: 7Phase 2: 7Phase 1: 1Phase 1: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 20Completed: 20Terminated: 8Terminated: 8Active, not recruiting: 7Active, not recruiting: 7Recruiting: 6Recruiting: 6Enrolling by invitation: 1Enrolling by invitation: 1